Clinical trials recruiting in Kew Gardens, New York

Phase breakdown

Conditions recruiting in Kew Gardens, New York

Recruiting trials in Kew Gardens, New York

• A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
  NCT06389136 · Phase: Phase 3 · Ages: 18 Years to 63 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
  NCT07037901 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female)
• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
  NCT07116967 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Kew Gardens, New York?

3 recruiting trials have at least one study site in Kew Gardens, New York.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.